Indiana Code 25-1-9.3-8. Prescription for controlled substance in written or faxed format or by oral order
(1) The prescriber cannot transmit an electronically transmitted prescription due to:
Terms Used In Indiana Code 25-1-9.3-8
- board: refers to the Indiana board of pharmacy established by IC 25-26-13-3. See Indiana Code 25-1-9.3-2
- controlled substance: has the meaning set forth in IC 35-48-1-9. See Indiana Code 25-1-9.3-3
- prescriber: means any of the following:
Indiana Code 25-1-9.3-5
- prescription: has the meaning set forth in IC 25-26-13-2. See Indiana Code 25-1-9.3-6
(B) the technological inability to issue a prescription electronically, including but not limited to failure to possess the requisite technology; or
(C) the inability of the dispensing pharmacy or provider to receive or process an electronically transmitted prescription.
(2) The prescriber issues a prescription to be dispensed by a pharmacy located outside Indiana.
(3) The prescriber and the pharmacist are the same entity.
(4) The prescriber issues a prescription that meets any of the following:
(A) The prescription contains elements that are not supported by the technical standards developed by the National Council for Prescription Drug Programs for electronically transmitted prescriptions (NCPDP SCRIPT).
(B) The federal Food and Drug Administration requires the prescription to contain certain elements that cannot be supported in an electronically transmitted prescription.
(C) The prescription is a non-patient specific prescription in response to a public health emergency or another instance allowable under state law and that requires a non-patient specific prescription under:
(i) a standing order;
(ii) approved protocol for drug therapy;
(iii) collaborative drug management; or
(iv) comprehensive medication management.
(D) The prescription is issued under a research protocol.
(5) The prescriber has received a waiver or a renewal of a previously received waiver from the board in accordance with rules adopted under section 9 of this chapter.
(6) The board, in accordance with rules adopted under section 9 of this chapter, has determined that issuing an electronically transmitted prescription would be impractical and cause delay, adversely impacting the patient’s medical condition.
(7) The prescriber reasonably determines that it would be impractical for the patient to obtain an electronic prescription in a timely manner and the delay would adversely affect the patient’s medical condition.
As added by P.L.28-2019, SEC.9. Amended by P.L.114-2020, SEC.8; P.L.207-2021, SEC.23.